Capital Bank & Trust’s CONMED CNMD Stock Holding History

Capital Bank & Trust’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26	Closed	-$3K	–	709
2019 Q4	$3K	Buy	+26	New	+$2.77K	﹤0.01%	638

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital Bank & Trust's CNMD Position: Q1 2020 in Review

Capital Bank & Trust sold out of CONMED (CNMD) in Q1 2020, closing a stake of 26 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in CNMD in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

Capital Bank & Trust reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
Capital Bank & Trust sold 26 CONMED shares in Q1 2020, an estimated $3K.
Capital Bank & Trust first reported a position in CONMED in Q4 2019 and held it in 1 quarter.
Capital Bank & Trust's CONMED position peaked at $3K in Q4 2019.
229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Capital Bank & Trust's 13F filing for Q1 2020, filed 15 May 2020.